retatrutide mechanism triple agonist glp-1 gip glucagon receptor Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Retatrutide the wonder drug: What's

Yet many patients are prescribed them with little discussion beyond body weight, nausea, constipation, and refill timing

Sources TRIUMPH trial design paper Diabetes, Obesity and Metabolism Phase 2 trial (NEJM) New England Journal of Medicine Phase 2 T2D trial (Lancet) The Lancet TRIUMPH-4 results Eli Lilly Investor Relations Related reading Retatrutide Calculator: Units & Reconstitution Interactive dose calculator, syringe-unit tables for every reconstitution setup, and projected weight loss by starting weight

Outside of an approved clinical trial, retatrutide should not be used at all in the UK

Content provided by Eden Morris, MS, RD, CIEC What are GLP-1 medications

The current Refund Policy states there is no guarantee of results or effectiveness, regardless of marketing language seen elsewhere

Many people hadnt even heard of GLP-1 before a couple of years ago